Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.

Published in: PloS one (2021)

The most effective antiviral agent in this study based on treatment duration was the combination of Oseltamivir + Hydroxychloroquine. The higher the patient's average treatment duration is, the lower the average survival rate for COVID-19 patients.

Keyphrases

healthcare
sars cov
case report
combination therapy
replacement therapy
electronic health record